flow trial semaglutide kidney outcomes nejm 2024 hazard ratio 0.76 Semaglutides Are Poised to Remake Chronic Disease Care Kidney Outcomes With Glucagon-Like Peptide-1

Jerry received a BS in Aerospace Engineering from the University of Texas and an MBA from Southern Methodist University

SGLT-2 inhibitors in patients with heart failure: a comprehensive meta-analysis of five randomized controlled trials

Systematic review of lifestyle interventions to improve weight, physical activity and diet among people with a mental health condition

Journal of Dermatological Science, 48, 141-144

Pheno Testing PhenoType Testing is a pioneering assessment that delves into your unique genetic makeup

Higher out-of-pocket costs for GLP-1 receptor agonists were linked to reduced adherence in type 2 diabetes patients, leading to increased hospitalizations, ED visits, and higher costs